Evidence map›Paper›PMID 42898463›Full record

ArticleNeurobiology of pain (Cambridge, Mass.)

The central neurometabolic fingerprint of persistent spinal pain syndrome type 2: A prospective [

Lara S Burmeister, Max van Grinsven, Bert-Kristian van Roosendaal, Richard L Witkam, Inge Arnts, Stephanie Janssen, Jessica Wegener, Kris C P Vissers, Anne I J Arens, Martin Gotthardt and 2 more

Abstract read
In one paragraph

Article in Neurobiology of pain (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lara S BurmeisterDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, Nijmegen, 6525GA, The Netherlands.
Max van GrinsvenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, Nijmegen, 6525GA, The Netherlands.
Bert-Kristian van RoosendaalDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, 6525GA, the Netherlands.
Richard L WitkamDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, 6525GA, the Netherlands.
Inge ArntsDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, 6525GA, the Netherlands.
Stephanie JanssenChronic Pain Department, Sint Maartenskliniek, Nijmegen, 6574NA, the Netherlands.
Jessica WegenerChronic Pain Department, Sint Maartenskliniek, Nijmegen, 6574NA, the Netherlands.
Kris C P VissersDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, 6525GA, the Netherlands.
Anne I J ArensDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, Nijmegen, 6525GA, The Netherlands.
Martin GotthardtDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, Nijmegen, 6525GA, The Netherlands.
Michael RullmannDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, 04103, Germany.
Dylan HenssenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, Nijmegen, 6525GA, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent spinal pain syndrome type 2 (PSPS-T2) is a disabling pain condition that persists after spinal surgery. While spinal cord stimulation (SCS) offers symptomatic relief, objective biomarkers to guide diagnosis and treatment are lacking. In this prospective cohort study, fifteen PSPS-T2 patients underwent dedicated [

Indexed as

[18F]FDG PET/CTBrain metabolismPersistent spinal pain syndrome type 2

Identifiers

PMID42898463
PMCPMC13678098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.